anti-vascular endothelial growth factor (VEGF) therapiesvenous occlusionmacular degenerationdiabetic macular oedemafaricimab Vabysmoaflibercept Eyleabevacizumab MVASIranibizumab RanivisioBevacizumabfaricimab+2 more
…e increased significantly in recent decades, driving demand for anti-vascular endothelial growth factor (VEGF) therapies. Compounding these agents into prefilled syringes optimises res…